Journal
CURRENT CLINICAL MICROBIOLOGY REPORTS
Volume 2, Issue 4, Pages 155-162Publisher
SPRINGER
DOI: 10.1007/s40588-015-0026-y
Keywords
Giardia; Gut pathogen; Microtubule; Motility; Attachment; Drug targets
Categories
Funding
- NIAID NIH HHS [R21 AI119791, R01 AI077571] Funding Source: Medline
Ask authors/readers for more resources
Giardia lamblia is a flagellated parasite of the gut and causes significant morbidity worldwide. Novel druggable targets are sorely needed due to Giardia's prevalence and the growing threat of antibiotic resistance. Giardia's conserved and unique cytoskeletal features, such as its eight flagella and ventral disc, are required for host colonization by facilitating motility, attachment, and cell division. Therapies that target these processes could interfere with trophozoite colonization, reduce the time or severity of the infection, and reduce the number of infectious cysts shed into the environment. This requires vetting and prioritizing critical cellular processes and identifying specific Giardia proteins in those processes as targets. It is time to leverage the wealth of data gathered through genome sequencing and proteomic studies, and new insights on the cytoskeleton of Giardia to design effective new drugs to treat giardiasis.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available